Ex-biotech Bio Green Med books fivefold revenue jump from Malaysian fire-safety line

Bio Green Med Solution, a Nasdaq-listed company that once worked in biopharma, said product sales in the third quarter of 2026 totalled $454,000, compared with $81,000 in the same period of 2025. The revenue comes from fire-safety products sold in Malaysia, the business it now operates.

The quarterly net loss came in at $0.4 million, which the company described as narrower. The material reviewed did not include the prior-year loss or any breakdown of costs, so the scale of the improvement cannot be measured here.

On the corporate side, the company reported that the Form S-4 registration statement covering its proposed business combination with Future NRG became effective in October. A shareholder meeting to vote on the deal is planned for November. No terms of the transaction were available in the material reviewed.

Bio Green Med holds $3.5 million in cash, which it expects to fund operations into the second quarter of 2027. The company's figures were published on 12 November 2026.